PharmaFlow offers disruptive innovation in biopharmaceuticals

Who would argue that we don’t need innovation in biopharmaceuticals? Some are even calling for disruptive innovation, to tackle the thorny issues of affordability and availability of new medical products.

Others are screaming “that’s impossible, never going to happen”.

It may surprise you to know it could be possible, and the work of the late, sadly depar…